LAURIE THORNTON: Open Payments
NPI 1609071265 · BRANDON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 15 payments from 9 companies in 2025. Trend: 2023 $13 · 2024 $216 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| ABBVIE INC. | 2 | $33 |
| PFIZER INC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| Medtronic, Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: MOUNJARO, JARDIANCE, XIFAXAN, VRAYLAR, NURTEC ODT, FARXIGA, Rybelsus, INTELLIS ADAPTIVESTIM.
Industry payments across MS — which companies pay providers there.
